4
Changes in Ownership
Neumora Therapeutics, Inc. Filed Acc 0000950170-25-022326
Options or other derivatives
- Director acquired 141,959 shares (grant or award)
- Director returned 141,959 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Fust Matthew K · Director
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-13 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −85,586 | 0 | D |
| 2025-02-13 | Returned to the company : show line 2 in the form Stock Option (Right to Buy) | −27,802 | 0 | D |
| 2025-02-13 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −28,571 | 0 | D |
| 2025-02-13 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +85,586 | 85,586 | D |
| 2025-02-13 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +27,802 | 27,802 | D |
| 2025-02-13 | Grant or award : show line 6 in the form Stock Option (Right to Buy) | +28,571 | 28,571 | D |
Loading xslF345X05/ownership.xml…